Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Japanese National Institute of Infectious Diseases to study Ampligen

Oct. 5, 2005

LigoCyte receives NIH grant for intranasal anthrax vaccine

Oct. 5, 2005

Amarillo updates low dose oral interferon progress

Oct. 5, 2005

Lck inhibition prevents acute rejection of heart transplants

Sep. 29, 2005

Pentacel BLA accepted for filing

Sep. 29, 2005

Altastaph recommended to receive orphan medicinal product status in Europe

Sep. 27, 2005

Nanobodies may substitute monoclonal antibodies

Sep. 26, 2005

Cytheris initiates additional phase I/II trial with recombinant interleukin-7

Sep. 22, 2005

Marketing suspension of Hexavac recommended by the EMEA

Sep. 21, 2005

Novel immunomodulating agents revealed in patents

Sep. 19, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026